drugset / Trial / NCT01309074

Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline

NCT01309074

Phase 4 Withdrawn Rush University Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the study is to compare the safety \& efficacy of sertraline (up to a dose of 200mg/day) \& pregabalin (up to a dose of 300mg/day) for the treatment of symptoms of anxiety in patients with epilepsy.

Timeline

Start
2009-11
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg
Comparator Sertraline Small molecule 200 mg

Indications